Dear Members,

    While this bulletin focuses on what has been mandatory cervical cancer vaccines for a number of (female)
    demographics including school aged girls in the UK, the products described below are also available and being
    promoted internationally. We felt this information was of particular interest to the media, our supporters, our members
    and certainly our general consumer readership... WINHS Newsletter Editor

    Dr. Diane Harper, the lead researcher in the development of two human papilloma (skin tumor) virus vaccines,
    “Gardasil” and “Cervarix,” said the controversial drugs actually does very little to reduce cervical cancer rates and,
    even though they're being recommended for girls as young as nine, there has been no efficacy trials in children under
    the age of 15.

    In a 180 degree reversal of her anticipated lecture done to promote the vaccines at the 4th International Public
    Conference on Vaccination in Reston, Virginia earlier this month,  Dr. Harper, who is the Director of the Gynecologic
    Cancer Prevention Research Group at the University of Missouri, left conference attendees convinced that the
    vaccine should not be administered.

    Joan Robinson, Assistant Editor at the Population Research Institute noted that she came away from the lecture with
    the perception that the risk of adverse side effects was so much greater than even the risk of cervical cancer, she
    couldn't help but question why the vaccine was even needed.   

Dr. Harper began her lecture explaining that 70 percent of all HPV infections (human papilloma virus infection) resolve without any treatment
within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only about half develop into
cervical cancer, which leaves little need for the vaccine.

Drug company paid PR and advertising campaigns to the contrary, Dr. Harper further surprised her audience as she went on to state that the
incidence of cervical cancer in the United States was already so low that "even if we get the vaccine and continue PAP screening, we will not
lower the rate of cervical cancer in the US."

Apparently conventional treatment and preventative measures are already cutting the cervical cancer rate by four percent a year. At this rate,
in 60 years, there will be a 91.4 percent decline just with current treatment.

Dr. Harper, who also serves as a consultant to the World Health Organization, further undercut the drug company argument promoting mass
vaccination by reporting that four out of five women with cervical cancer are located in developing countries – not the US.

Ms. Robinson, again the Assistant Editor at the Population Research Institute, said she could not help but wonder, "If this is the case, then
why vaccinate at all? But from the murmurs of the numerous doctors in the audience, it was apparent that the same thought was occurring to

However, at this point, Dr. Harper dropped an even bigger bombshell on the audience when she announced that, "There have been no
efficacy trials (for these vaccines) in girls under 15 years."

In fact, Merck, the pharmaceutical giant and manufacturer of the Gardasil vaccine, studied only a very small group of girls under 16 who had
been vaccinated, but then did not follow them long enough to conclude sufficient presence of effective HPV antibodies – nor any resultant
side effects.

This is not the first time Dr. Harper revealed the fact that Merck never tested Gardasil for safety in young girls. During a 2007 interview with
Indiana’s KPC News, a local she said giving the vaccine to girls as young as 11 years-old "is a great big public health experiment."

At the time, which was at the height of Merck's controversial drive to have the vaccine mandated in schools, Dr. Harper remained steadfastly
opposed to the idea and said she had been trying for months to convince major television and print media about her concerns, "but no one
would print it."

"It is silly to mandate vaccination of 11 to 12 year old girls," she said at that time. "There also is not enough evidence gathered on side
effects to know that safety is not an issue." And, when asked why she was speaking out, she said: "I want to be able to sleep with myself
when I go to bed at night."


Since the drug's introduction in 2006, the public has been learning many of the facts the hard way. To date, 15,037 girls have officially
reported adverse side effects from Gardasil to the Vaccine Adverse Event Reporting System (VAERS). These adverse reactions include
Guillain Barre*, lupus, seizures, paralysis, blood clots, brain inflammation and many others. The Center for Disease Control (CDC)
acknowledges that there have been 44 reported deaths.

*Guillain-Barre syndrome: A disorder characterized by progressive symmetrical paralysis and loss of reflexes, usually beginning in the legs

Dr. Harper also participated in the research on Glaxo-Smith-Kline's version of the drug, Cervarix, currently in use in the UK, but not yet
approved in the US drug “market.”

Since the British government began administering the vaccine to school-aged girls last year, more than 2,000 patients reported some kind
of adverse reaction including nausea, dizziness, blurred vision, convulsions, seizures and hyperventilation. Several reported multiple
reactions, with 4,602 suspected side-effects recorded in total.

The most tragic case involved a 14 year-old girl who dropped dead in the corridor of her school an hour after receiving the vaccination.

The outspoken researcher also weighed in last month on a report published in the Journal of the American Medical Association that raised
questions about the safety of the vaccine, saying bluntly:
"The rate of serious adverse events is greater than the incidence rate of
cervical cancer."

Ms. Robinson said she respects Dr. Harper's candor. "I think she's a scientist, a researcher, and she's genuine enough a scientist to be
open about the risks. I respect that in her. For me, it was hard to resist the conclusion that Gardasil does almost nothing for the health of
American women."

We recommend that you forward this article to your friends, associates and family members who have young daughters – a certain target of
the PR and marketing campaigns driving these “wonder” drug vaccines and targeting them and their parents. At least they will be informed
and can make their own educated decision.

All the best,


Rudi C. Loehwing
Managing Director
World Institute of Natural Health Sciences

The "Business" of Drugs: Lead Product Researcher Drops
PR Bombshell on Cervical Cancer Vaccine's in the UK.
Page created 8/9/09
WINHS Logo World Institute Natural Health Services
This file is not intended to be viewed directly using a web browser. To create a viewable file, use the Preview in Browser or Publish to Yahoo! Web Hosting commands from within Yahoo! SiteBuilder.